An Investigational Scan (Me-4FDG PET/CT) for the Detection of Sodium-Glucose Transport for Early Diagnosis of Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Lung Adenocarcinoma
Related studies linked through entity extraction aliases.
I3LUNG: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy
- Status
- RECRUITING
- Phase
- N/A
Osimertinib to Suppress the Progression of Remaining GGN for EGFR Mutation-positive Stage IB-IIIA Lung Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE2
A Single-arm Exploratory Study of Neoadjuvant Therapy
- Status
- RECRUITING
- Phase
- NA
Diagnostic Yeld of Ultrathin Bronchoscopy in Peripheral Pulmonary Lesions
- Status
- RECRUITING
- Phase
- N/A
Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection
- Status
- RECRUITING
- Phase
- N/A
AMT-151 in Patients With Selected Advanced Solid Tumours
- Status
- RECRUITING
- Phase
- PHASE1
Radiomics Combined With Frozen Section Prediction Model for Spread Through Air Space in Lung Adenocarcinoma
- Status
- UNKNOWN
- Phase
- N/A
Exhaled Breath Particles in Lung Cancer
- Status
- UNKNOWN
- Phase
- N/A
The Effect of Interventional Pulmonary Rehabilitation Exercise With Advanced Lung Cancer.
- Status
- UNKNOWN
- Phase
- NA
Pembrolizumab Plus Bevacizumab and Chemotherapy for ALK-rearranged NSCLC With Persistent 5'ALK
- Status
- RECRUITING
- Phase
- PHASE2
Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Shared Decision Making in Patients With Lung Cancer
- Status
- RECRUITING
- Phase
- N/A
Evaluation of the Response to Tyrosine Kinase Inhibitors in Localized Non-small Cell Lung Cancer (NSCLC) Patients With EGFR Mutation in a Patient-derived Organoid Model
- Status
- UNKNOWN
- Phase
- N/A
Milademetan in Advanced/Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Identify Prognostic Biomarkers of Lung Cancer
- Status
- UNKNOWN
- Phase
- N/A
Furmonertinib as Perioperation Therapy in Stage IIIA-IIIB (N1-N2) Resectable EGFR Mutated Lung Adenocarcinoma (FRONT)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm
- Status
- RECRUITING
- Phase
- NA
Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 Negative
- Status
- SUSPENDED
- Phase
- PHASE2/PHASE3
Radiomics-based Prediction Model of Tumor Spread Through Air Space in Lung Adenocarcinoma
- Status
- COMPLETED
- Phase
- N/A